# Biliopancreatic diversion with duodenal switch improve polycystic ovary syndrome with decreased serum ceramides

**Authors:** Xiaochuan Li, Haomin Chen, Pengyu Li, Mingfei Wang, Dalin Wu, Juan Liu, Weijie Chen

PMC · DOI: 10.3389/fendo.2026.1720242 · Frontiers in Endocrinology · 2026-02-05

## TL;DR

This study shows that a specific weight-loss surgery improves PCOS symptoms in rats by reducing insulin resistance and altering bile acid and ceramide levels.

## Contribution

The study demonstrates that BPD/DS surgery improves PCOS through reduced serum ceramides and increased bile acids, with reversal upon bile acid sequestration.

## Key findings

- BPD/DS surgery significantly improved insulin resistance and reproductive disorders in PCOS rat models.
- Bile acid levels increased and ceramide levels decreased in the BPD/DS group compared to the sham group.
- Bile acid sequestration reversed the improvement in insulin resistance and increased ceramide levels.

## Abstract

Polycystic ovary syndrome (PCOS) is characterized primarily by insulin resistance and reproductive disorders. Biliopancreatic diversion with duodenal switch (BPD/DS) could significantly improve insulin sensitivity with significantly elevated level of bile acids. We aimed to explore changes in PCOS manifestations after BPD/DS and the possible mechanisms.

Twenty PCOS rat models were assigned into the BPD/DS group and the sham BD (S-BPD) group randomly. The fasting blood glucose, bile acids, and ceramides levels in serum samples were assessed.

The reproductive disorders of BPD/DS group were almost completely restored 8 weeks after surgery, and the AUCOGTT value and the AUCITT value were statistically less than those of the S-BPD group (P =0.001). The concentration of serum testosterone, luteinizing hormone, and follicle-stimulating hormone of the BPD/DS group was statistically less than that of the S-BPD group (P <0.05). Moreover, high level of bile acids and low level of ceramides were observed in the BPD/DS group (P <0.001). Bile acid sequestrant was given to the BPD/DS group rats for 1 week, the level of bile acids decreased and ceramides increased, the insulin resistance worsened. The AUCOGTT value increased from 818.3 ± 297.3 mmol/L·min to 1147.9 ± 167.9 mmol/L·min (P =0.007) and the AUCITT value increased from 525.6 ± 52.3 mmol/L·min to 577.7 ± 102.9 mmol/L·min (P =0.023).

Our study showed the improvement of insulin resistance in PCOS models after BPD/DS with decreased serum ceramides. The sequestrant of bile acid reversed the improvement of insulin resistance with higher ceramides level.

## Linked entities

- **Chemicals:** testosterone (PubChem CID 6013), follicle-stimulating hormone (PubChem CID 62819)
- **Diseases:** polycystic ovary syndrome (MONDO:0008487)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** PRKCZ (protein kinase C zeta) [NCBI Gene 5590] {aka PKC-ZETA, PKC2}, Shbg (sex hormone binding globulin) [NCBI Gene 24775] {aka Abpa}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, Agxt (alanine--glyoxylate aminotransferase) [NCBI Gene 24792] {aka AGT, SPT, Spat}, Amh (anti-Mullerian hormone) [NCBI Gene 25378] {aka MIS}, Bscl2 (BSCL2 lipid droplet biogenesis associated, seipin) [NCBI Gene 361722]
- **Diseases:** preterm delivery (MESH:D047928), cardiovascular disease (MESH:D002318), endocrine and metabolic disorders (MESH:D004700), infertility (MESH:D007246), Bodyweight (MESH:D015431), Insulin resistance (MESH:D007333), anovulation (MESH:D000858), PCOS (MESH:D011085), hyperinsulinism (MESH:D006946), glucose tolerance impairment (MESH:D018149), lipid (MESH:D011017), type 2 diabetes (MESH:D003924), miscarriage (MESH:D000022), androgen (MESH:D014770), abdominal infection (MESH:D000007), ovulatory failure (MESH:D051437), diabetes (MESH:D003920), preeclampsia (MESH:D011225), neurodegenerative diseases (MESH:D019636), metabolic syndrome (MESH:D024821), hyperglycemia (MESH:D006943), reproductive disorders (MESH:D060737), BD (MESH:D004382), obese (MESH:D009765), Overweight (MESH:D050177)
- **Chemicals:** fatty acyl-CoAs (MESH:D000214), fatty acid (MESH:D005227), carbohydrate (MESH:D002241), C18:0 ceramides (-), DS (MESH:D003903), S (MESH:D013455), bile acid (MESH:D001647), CLS (MESH:D002792), sphingolipids (MESH:D013107), alcohol (MESH:D000438), butanol (MESH:D000440), Glucose (MESH:D005947), SPB (MESH:C042995), reactive oxygen species (MESH:D017382), Ketamine (MESH:D007649), DHEA (MESH:D003687), Lipids (MESH:D008055), E2 (MESH:D004958), triglycerides (MESH:D014280), carbon (MESH:D002244), pentobarbital sodium (MESH:D010424), methanol (MESH:D000432), ammonium formate (MESH:C030544), salt (MESH:D012492), myriocin (MESH:C001996), progesterone (MESH:D011374), isopropanol (MESH:D019840), cholesterol (MESH:D002784), Blood glucose (MESH:D001786), Ceramide (MESH:D002518), BPD (MESH:C017228), free fatty acid (MESH:D005230), C18:0 (MESH:C031183), Testosterone (MESH:D013739)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** 3T3L1 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0123)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12916421/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12916421/full.md

## References

36 references — full list in the complete paper: https://tomesphere.com/paper/PMC12916421/full.md

---
Source: https://tomesphere.com/paper/PMC12916421